ask="N/A"
ask_size="N/A"
average_daily_volume="1093510"
bid="41.20"
bid_size="100"
book_value="4.05"
change="-0.92"
change_from_200_day_moving_average="-1.96"
change_from_50_day_moving_average="3.06"
change_from_52_week_high="-10.71"
change_From_52_week_low="12.26"
change_in_percent="-2.03%"
close="44.44"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.63"
eps_estimate_next_quarter="-0.48"
eps_estimate_next_year="-1.92"
ex_dividend_date="N/A"
float_shares="85781000"
high="45.20"
high_52_weeks="55.15"
last_trade_date="2/10/2017"
last_trade_price="44.44"
last_trade_size="26510"
last_trade_time="4:00pm"
low="43.95"
low_52_weeks="32.18"
market_capitalization="3.86B"
moving_average_200_day="46.40"
moving_average_50_day="41.38"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="66.92"
open="44.45"
pe_ratio="N/A"
peg_ratio="0.76"
percent_change_from_200_day_moving_average="-4.22%"
percent_change_from_50_day_moving_average="+7.40%"
percent_change_from_52_week_high="-19.42%"
percent_change_from_52_week_low="+38.10%"
previous_close="45.36"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="11.21"
price_per_sales="262.70"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.10"
stock_exchange="NMS"
symbol="NBIX"
volume="1238520"
weeks_range_52="32.18 - 55.15"
